#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Intracranial calcification Hypophosphatasia Spinal muscular atrophy Neuromyelitis optica spectrum disorder Enteritis Sickle cell anaemia Leukodystrophy Alpha-1 antitrypsin deficiency Retinal artery occlusion Fibrous dysplasia of bone Small intestine leiomyosarcoma Burkitt's lymphoma refractory Ventricular fibrillation Ovarian cancer stage IV Autologous haematopoietic stem cell transplant More trials…

    Learn about Rare Diseases

    Synovial sarcoma recurrent – Trials in Disease Epidermolysis bullosa – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Testicular leiomyosarcoma – Life with Disease Glomerulonephritis rapidly progressive – Basic Information Focal segmental glomerulosclerosis – Diagnostics Shprintzen-Goldberg syndrome – Basic Information Undifferentiated sarcoma – Diagnostics Congenital hypotransferrinaemia – Trials in Disease Congenital generalised lipodystrophy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Telitacicept Rimegepant Alisertib Sodium Cladribine Misoprostol Rasburicase Pf-06480605 Acetylcysteine Amide Alrefimotide Alxn2220 Doxycycline CHONDROITIN SULFATE SODIUM Galcanezumab Belimumab Dextrose Bp Faricimab Milvexian 99MTC-EUK-(SO3)CY5-MAS3 Gabapentin Tapderimotide More therapies…

    Learn about Your Condition

    Rhabdomyosarcoma Colon cancer metastatic Staphylococcal bacteraemia Lichen sclerosus Cystic fibrosis Coagulopathy Peripheral spondyloarthritis Colon cancer Netherton's syndrome H1N1 influenza CDKL5 deficiency disorder Corneal dystrophy Anal squamous cell carcinoma Colonoscopy Paraesthesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cluster headache

  • Study on the Effects of Lysergide for Patients with Chronic Cluster Headache

    Recruiting

    2 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands

  • Study on Cluster Headache Using Befiradol (18F) for Patients with Episodic Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Befiradol (18F)
    France

  • Study on Botulinum Toxin Type A and Sodium Chloride for Patients with Treatment-Resistant Chronic Cluster Headache

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Germany Norway

  • Sodium Oxybate for Nocturnal Cluster Headache Attacks in Adults with Chronic Cluster Headache: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Sodium Oxybate
    The Netherlands

  • A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Candesartan
    Denmark Norway

  • A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Candesartan
    Denmark Norway
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!